|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||121.43 - 121.43|
|52-week range||99.71 - 124.80|
|Beta (5Y monthly)||0.28|
|PE ratio (TTM)||41.21|
|Forward dividend & yield||0.83 (0.68%)|
|Ex-dividend date||06 Apr 2021|
|1y target est||N/A|
Nivea maker Beiersdorf's sales rose above pre-pandemic levels as demand for adhesives and its dermatological brands roared back, pushing the shares up by more than 5% in early trade on Thursday. Organic sales jumped 28.3% in the second quarter to deliver growth for the first half of 16.2%, achieving 3.87 billion euros revenue, a tad above the consensus estimate of 3.82 billion according to Refinitiv IBES data and the 2019 first-half figure of 3.84 billion euros. Beiersdorf's shares were up 5.5% at 0735 GMT, having earlier hit their highest level since early 2020.
Nivea maker Beiersdorf on Wednesday named board member Vincent Warnery as its new CEO to take over from May 1, as it confirmed a rise in first-quarter sales driven by strong demand for adhesives and its dermatological brands. Beiersdorf said Stefan de Loecker will step down after a little more than two years in the job. Under de Loecker's leadership, Beiersdorf invested more in its consumer business to counter a drop in sales growth and bought U.S. sun care brand Coppertone from Bayer for $550 million to strengthen its position in North America.
Beiersdorf Aktiengesellschaft / Key word(s): PersonnelBeiersdorf Aktiengesellschaft: Change in the Chair of the Executive Board27-Apr-2021 / 18:41 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Change in the Chair of the Executive Board At today's meeting, the Supervisory Board of Beiersdorf Aktiengesellschaft, Hamburg, and the Chairman of the Executive Board, Stefan De Loecker, reached an amicable agreement that he will resign from the Executive Board as of 30 June 2021.The Supervisory Board appointed Vincent Warnery, currently responsible in the Executive Board for the "Pharmacy & Selective" as well as for the North America business, as Chairman of the Executive Board of the company with effect from 1 May 2021. The Supervisory Board also extended Mr. Warnery's appointment for a further five years until 31 January 2027.Contact:Dr. Jens GeißlerHead of Investor RelationsTel.: +49 (40) 4909 5000Fax: +49 (40) 4909 18 5000Anke SchmidtHead of Corporate CommunicationsTel.: +49 (40) 4909 2001Fax: +49 (40) 4909 251627-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: Beiersdorf Aktiengesellschaft Unnastraße 48 20245 Hamburg Germany Phone: +49 (0)40 4909-0 Fax: +49 (0)40 4909-34 34 E-mail: kontakt@Beiersdorf.com Internet: www.Beiersdorf.com ISIN: DE0005200000 WKN: 520000 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Dusseldorf, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1189537 End of Announcement DGAP News Service